121 related articles for article (PubMed ID: 11385494)
1. Imaging metalloproteinase activity in vivo.
Zucker S; Cao J
Nat Med; 2001 Jun; 7(6):655-6. PubMed ID: 11385494
[No Abstract] [Full Text] [Related]
2. Snapshots of the reaction mechanism of matrix metalloproteinases.
Bertini I; Calderone V; Fragai M; Luchinat C; Maletta M; Yeo KJ
Angew Chem Int Ed Engl; 2006 Dec; 45(47):7952-5. PubMed ID: 17096442
[No Abstract] [Full Text] [Related]
3. [Matrix metalloproteinase inhibitors].
Nakajima M
Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1083-9. PubMed ID: 10771677
[No Abstract] [Full Text] [Related]
4. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
Zucker S; Cao J; Chen WT
Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
[TBL] [Abstract][Full Text] [Related]
5. Increase of anti-metastatic efficacy by selectivity- but not affinity-optimization of synthetic serine protease inhibitors.
Banke IJ; Arlt MJ; Pennington C; Kopitz C; Steinmetzer T; Schweinitz A; Gansbacher B; Quigley JP; Edwards DR; Stürzebecher J; Krüger A
Biol Chem; 2003; 384(10-11):1515-25. PubMed ID: 14669995
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin. Cancer Res., 9: 00-00, 2003.
Rundhaug JE
Clin Cancer Res; 2003 Feb; 9(2):551-4. PubMed ID: 12576417
[No Abstract] [Full Text] [Related]
7. [Involvement of matrix metalloproteinases (MMPs) in cutaneous melanoma progression].
Ntayi C; Hornebeck W; Bernard P
Pathol Biol (Paris); 2004 Apr; 52(3):154-9. PubMed ID: 15063935
[TBL] [Abstract][Full Text] [Related]
8. [Tumor metastasis and MMP inhibitor].
Sato H
Clin Calcium; 2006 Apr; 16(4):621- 26. PubMed ID: 16582513
[TBL] [Abstract][Full Text] [Related]
9. [Matrix metalloproteinases. Point of attack for a new cancer therapy].
Med Monatsschr Pharm; 2001 Jan; 24(1):2-5. PubMed ID: 11210858
[No Abstract] [Full Text] [Related]
10. Matrix metalloproteinase sensitive gold nanorod for simultaneous bioimaging and photothermal therapy of cancer.
Yi DK; Sun IC; Ryu JH; Koo H; Park CW; Youn IC; Choi K; Kwon IC; Kim K; Ahn CH
Bioconjug Chem; 2010 Dec; 21(12):2173-7. PubMed ID: 21062090
[TBL] [Abstract][Full Text] [Related]
11. [Matrix metalloproteinases and their role in cancer progression].
Przybyłowska K; Błasiak J
Postepy Biochem; 2001; 47(3):212-23. PubMed ID: 11908090
[No Abstract] [Full Text] [Related]
12. Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.
Le Diguarher T; Chollet AM; Bertrand M; Hennig P; Raimbaud E; Sabatini M; Guilbaud N; Pierré A; Tucker GC; Casara P
J Med Chem; 2003 Aug; 46(18):3840-52. PubMed ID: 12930146
[TBL] [Abstract][Full Text] [Related]
13. [Matrix metalloproteinases and colorectal cancer].
Roeb E; Matern S
Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of a novel matrix metalloproteinase inhibitor on pancreatic adenocarcinoma cells in vitro and in an orthotopic pancreatic cancer model in vivo.
Kapischke M; Fischer T; Tiessen K; Tschesche H; Bruch HP; Kalthoff H; Kruse ML
Int J Oncol; 2008 Jan; 32(1):273-82. PubMed ID: 18097568
[TBL] [Abstract][Full Text] [Related]
15. Dystroglycan complex in cancer.
Brennan PA; Jing J; Ethunandan M; Górecki D
Eur J Surg Oncol; 2004 Aug; 30(6):589-92. PubMed ID: 15256230
[TBL] [Abstract][Full Text] [Related]
16. Extracellular proteases as targets for treatment of cancer metastases.
Lee M; Fridman R; Mobashery S
Chem Soc Rev; 2004 Sep; 33(7):401-9. PubMed ID: 15354221
[TBL] [Abstract][Full Text] [Related]
17. A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents.
Ribba B; Saut O; Colin T; Bresch D; Grenier E; Boissel JP
J Theor Biol; 2006 Dec; 243(4):532-41. PubMed ID: 16930628
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and cancer.
Cox G; O'Byrne KJ
Anticancer Res; 2001; 21(6B):4207-19. PubMed ID: 11908674
[TBL] [Abstract][Full Text] [Related]
19. [Matrix metalloproteinase in human gastric carcinoma].
Adachi Y; Itoh F; Imai K
Nihon Rinsho; 2001 Apr; 59 Suppl 4():107-12. PubMed ID: 11424366
[No Abstract] [Full Text] [Related]
20. Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291.
Naglich JG; Jure-Kunkel M; Gupta E; Fargnoli J; Henderson AJ; Lewin AC; Talbott R; Baxter A; Bird J; Savopoulos R; Wills R; Kramer RA; Trail PA
Cancer Res; 2001 Dec; 61(23):8480-5. PubMed ID: 11731431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
